ELANE and infection: More specifically, key therapeutic approaches to modulate neutrophil function may include targeting neutrophil development and production [216], inhibiting neutrophil accumulation at sites of infection or inflammation [217, 218, 219, 220], or reducing the adverse effects of neutrophil‐derived products like NE, MPO, or NETs [221, 222, 223].